Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 1,981–2,040 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

A&E1 ACCORD1 ADSTILADRIN1 AGENAS1 AGU1 AIC Kijabe Hospital1 AKUH1 ALERT Comprehensive Specialised Hospital1 ALSWH1 AMBOSS1 ANRS-PREVENIR1 ANZCRT1 APPAC IV1 ATC group C071 AZUR-21 Aalen University1 Agogo Presbyterian Hospital1 Albany Medical College1 Aliment Pharmacol Ther1 Allegheny Health1 AllofUS1 Alomone Labs1 American Dental Association1 American Journal of Gastroenterology1 American Society of Transplantation1 Amiens-Picardie University Hospital1 Aneuvas Technologies, Inc1 Archambault et al1 Arm 31 Asociación Latinoamericana para el Estudio del Hígado1 AstraZeneca1 Atrium Health Carolinas Medical Center1 BD Biosciences1 BE MOBILE 11 BIDMC1 BIOME study1 BMHI1 BSGE1 BSU1 BabyGel trial1 Baxter et al1 Beijing1 Beijing Friendship Hospital1 Beijing Huilongguan Hospital1 Benchmark-SLE1 BioMedware1 BioMere1 BornFyne1 Boston University Medical Center1 Brain Aneurysm Foundation1 Brain-Heart team1 Brightline1 Bristol Myers Squibb1 British Menopause Society1 BronchUK Registry1 Brown University Health Institutional Review Board1 C-STACS1 CAMP1 CANN20211 CASEM1

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 572 of 946

4CPS-029 Long-term use of cladribine in multiple sclerosis

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

95.0%

tertiary hospital Cladribine relapsing–remitting multiple sclerosis RRMS DMT

…erial and Methods A retrospective analysis was carried out at a tertiary hospital, including patients treated with cladribine between January 202…

4CPS-031 Real-world outcomes of the combination of trifluridine/tipiracil and bevacizumab in metastatic colorectal cancer

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

77.2%

Eastern Cooperative Oncology Group Colorectal cancer bevacizumab TAS mCRC trifluridine/tipiracil BEV

…tals between January 2023 and July 2025.Patient data (age, sex, Eastern Cooperative Oncology Group (ECOG) performance status, KRAS mutation status, prior treatmen…

4CPS-032 Effectiveness and safety of off-label verteporfin photodynamic therapy in chronic central serous chorioretinopathy

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

90.7%

tertiary university hospital verteporfin Chronic central serous chorioretinopathy (cCSC)photodynamic therapy

…of off-label verteporfin PDT in patients with cCSC treated in a tertiary university hospital.Material and Methods A retrospective observational study was co…

4CPS-037 Selection of patients for pharmaceutical medication management: development and implementation of a digital point-based tool in electronic patient journal system

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

79.1%

emergency department opioids blood thinners antidiabetics pharmaceutical intervention medication review

…he digital point-based tool was presented and implemented in an emergency department. The pharmacists developed a new workflow prioritising patients…

4CPS-038 Effectiveness of secukinumab in hidradenitis suppurativa: real-world data

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

78.0%

secondary-level hospital secukinumab adalimumab Hidradenitis suppurativa (HS)IL-17

…Single-centre, retrospective observational study conducted in a secondary-level hospital (January 2021–February 2025). Adult patients with HS treated wi…

4CPS-042 From risk stratification to follow-up: prevalence and management of cardiovascular events associated with trastuzumab

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

91.2%

tertiary hospital trastuzumab breast cancer gastroesophageal cancer left ventricular dysfunction heart failure

…d with trastuzumab as the only cardiotoxic anti-HER2 agent in a tertiary hospital between January2024-June2025.Prior to treatment, demographic, c…

4CPS-044 Comparison of the effectiveness of atogepant combined with botulinum toxin versus atogepant monotherapy in the prevention of chronic migraine

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

78.8%

tertiary hospitals chronic migraine atogepant CM BTX-ATO ATOm

…bservational, retrospective, multicentre study conducted in two tertiary hospitals in patients with CM treated with atogepant for at least 3 month…

4CPS-045 Optimisation of antiemetic therapy based on individual response in colorectal cancer patients treated with moderately emetogenic chemotherapy

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

94.0%

Oncohaematology Pharmaceutical Care Clinic colorectal cancer XELOX Cetuximab Irinotecan Bevacizumab moderately emetogenic chemotherapy palonosetron netupitant

…nic chemotherapy were included.Follow-up was carried out in the Oncohaematology Pharmaceutical Care Clinic through structured clinical interviews after each cycle. Clinic…

4CPS-046 Evaluation of antibiotic use in patients admitted to the intensive care unit (ICU) with pneumonia and sepsis: retrospective observational before-after study

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

78.2%

University of Debrecen pneumonia sepsis fluoroquinolones AB

…term effect.References and/or Acknowledgements Supported by the University of Debrecen Program for Scientific Publication.Conflict of Interest No conf…

4CPS-047 Evaluation of the empiric antibiotic use pattern and outcomes in patients admitted at ICU with pneumonia and sepsis with different respiratory support

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

78.0%

Pulmonology Department sepsis pneumonia

…ne 2018 and February 2024 at the Intensive Care Unit (ICU) of a Pulmonology Department of a tertiary care medical centre in Hungary. During the intens…

4CPS-048 Can intradialytic parenteral nutrition improve nutritional parameters in haemodialysis patients?

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

81.2%

tertiary hospital malnutrition

…vational, retrospective, multidisciplinary study conducted in a tertiary hospital including adult patients receiving IDPN for >6months (2021-Janu…

4CPS-052 Intravitreal dexamethasone implant for the treatment of diabetic macular oedema and macular oedema secondary to retinal vein occlusion: effectiveness evaluation

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

90.8%

Hospital faricimab aflibercept diabetic macular oedema bevacizumab macular oedema dexamethasone retinal vein occlusion RVO DME

…cal effectiveness of intravitreal dexamethasone implants in our Hospital from 2023 to 2024.Material and Methods Patients’ data were obta…